Whole-body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [11C]-NE40 in healthy subjects.
about
TSPO imaging in parkinsonian disordersTargeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative DisordersMolecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.Alterations in the Medullary Endocannabinoid System Contribute to Age-related Impairment of Baroreflex Sensitivity.Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of NeuroinflammationSynthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor.The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophagesImaging of neuroinflammation in parkinsonian syndromes with positron emission tomography.Development of (18)F-labeled radiotracers for neuroreceptor imaging with positron emission tomographyPET imaging of cannabinoid type 2 receptors with [11C]A-836339 did not evidence changes following neuroinflammation in rats.Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks.Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.Radioligands for positron emission tomography imaging of cannabinoid type 2 receptor.Comparison of dosimetry between PET/CT and PET alone using (11)C-ITMM.Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational frameworkRadiofluorination and biological evaluation of N-aryl-oxadiazolyl-propionamides as potential radioligands for PET imaging of cannabinoid CB2 receptors
P2860
Q26747214-F133ACDF-775E-43EE-88C4-5946AF837713Q28073952-813A7ED6-479B-4194-9CF3-8CAFAE5157D7Q33624653-03605811-EE29-4BD1-B13A-5491C9FF75E4Q35582616-308D6F3B-8500-48AB-933F-83020D51D3CFQ35667387-8C6855C2-7135-4B31-BBA9-448F712F4A97Q37689804-FCAD8430-0A56-48A7-A901-D1BC04A43FABQ37718217-177BAA0C-5930-44F3-BAFF-0889761D3C8FQ38154242-B393179D-6F7D-4ECE-AABB-6963287CD528Q38244707-5EB32786-69B7-4231-B2DA-AB542C04F020Q38771463-3E7951E7-39BF-4039-94C1-5171B8988479Q39033807-8D0D0D8F-E142-40FC-BD27-971E30883929Q39135834-39F71688-518F-4173-9DB1-9235E4FD43CFQ39527199-9398E994-8B2E-419F-8231-BCDF10EA251DQ47432979-73B475C7-EC3F-4BA6-AB0C-B4CEE19FDA63Q50273376-C2003B2D-26C0-48D2-9BBF-A01648B2C798Q58788199-B8A1F71D-B01D-4F14-97B6-A3A43B3582ECQ59302801-C292E3DB-D85A-4F84-A172-1CB9537DD40D
P2860
Whole-body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [11C]-NE40 in healthy subjects.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Whole-body biodistribution and ...... 11C]-NE40 in healthy subjects.
@en
Whole-body biodistribution and ...... 11C]-NE40 in healthy subjects.
@nl
type
label
Whole-body biodistribution and ...... 11C]-NE40 in healthy subjects.
@en
Whole-body biodistribution and ...... 11C]-NE40 in healthy subjects.
@nl
prefLabel
Whole-body biodistribution and ...... 11C]-NE40 in healthy subjects.
@en
Whole-body biodistribution and ...... 11C]-NE40 in healthy subjects.
@nl
P2093
P2860
P921
P1476
Whole-body biodistribution and ...... 11C]-NE40 in healthy subjects.
@en
P2093
Alfons Verbruggen
Guy Bormans
Kim Serdons
Koen Van Laere
Michel Koole
Nele Evens
Rawaha Ahmad
P2860
P2888
P304
P356
10.1007/S11307-013-0626-Y
P577
2013-08-01T00:00:00Z
P6179
1016416862